HighMark Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.24K	Hold	75	–	–	﹤0.01%	399
2025 Q4	$4.46K	Hold	75	–	–	﹤0.01%	420
2025 Q3	$4.06K	Hold	75	–	–	﹤0.01%	422
2025 Q2	$4.12K	Hold	75	–	–	﹤0.01%	419
2025 Q1	$5.3K	Hold	75	–	–	﹤0.01%	366
2024 Q4	$4.93K	Hold	75	–	–	﹤0.01%	384
2024 Q3	$5.27K	Hold	75	–	–	﹤0.01%	395
2024 Q2	$6.17K	Hold	75	–	–	﹤0.01%	355
2024 Q1	$6.55K	Hold	75	–	–	﹤0.01%	347
2023 Q4	$7.23K	Hold	75	–	–	0.01%	315
2023 Q3	$6.64K	Sell	75 -75	-50%	-$6.67K	0.01%	314
2023 Q2	$13K	Hold	150	–	–	0.01%	228
2023 Q1	$14.6K	Hold	150	–	–	0.01%	244
2022 Q4	$15.5K	Hold	150	–	–	0.01%	195
2022 Q3	$13K	Hold	150	–	–	0.01%	200
2022 Q2	$12K	Hold	150	–	–	0.01%	219
2022 Q1	$12K	Hold	150	–	–	0.01%	236
2021 Q4	$13K	Sell	150 -152	-50%	-$12.5K	0.01%	223
2021 Q3	$23K	Buy	+302	New	+$23.8K	0.02%	170
2020 Q3	–	Sell	-69	Closed	-$9K	–	447
2020 Q2	$9K	Buy	+69	New	+$6.86K	0.01%	212